Scarica l'app Stockscreener
340.41
1.20%
4.02
Dopo l'orario di chiusura:
340.41
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché WST Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
West Pharmaceutical Services Inc Borsa (WST) Ultime notizie
West Pharmaceutical Services Inc (WST)'s Winning Formula: Financ - GuruFocus
West Pharmaceutical Services stock hits 52-week high at $338.73 - Investing.com
West Pharmaceutical Services stock hits 52-week high at $338.73 By Investing.com - Investing.com Canada
Is West Pharmaceutical stock outperforming the S&P 500? - MSN
West Pharmaceutical Services Inc (WST) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
West Pharmaceutical Services, Inc. (WST) hit a 52 week high, can the run continue? - MSN
The SmartDose 10 mL system from West Pharmaceutical Services Inc.large-volume self-injection with - Ad-hoc-news.de
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
West Pharmaceutical opens the week with clear analyst consensus, shares hold near recent highs - Ad-hoc-news.de
Revvity Launches Signals AI to Advance Scientific R&D Workflows - TradingView
West Pharmaceutical Services names Michel Lagarde as next CEO, effective Aug. 31 - MSN
The NovaPure Plunger from West Pharmaceuticaltight particle specs for sensitive biologics - AD HOC NEWS
West Pharmaceutical StockSunday background on valuation and growth drivers - AD HOC NEWS
West Pharmaceutical Services (WST) Stock Could Be 6.9% Undervalued on GLP 1 Growth Narrative - Yahoo Finance
Why West Pharmaceutical’s NovaGuard SA Pro quietly matters for everyday injections - AD HOC NEWS
CAH Stock Up Nearly 8% YTD: Will the Uptrend Continue in the Rest of 2026? - TradingView
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
COR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell? - TradingView
West Pharmaceutical Services Inc (WST) Valuation: PE, PB & Fair Value Analysis - TradingKey
Cencora Launches Enhanced Nucleus Solution for Specialty Practices - TradingView
West Pharmaceutical stock under pressure after weekly high as technicals suggest range trading ahead - Traders Union
West Pharmaceutical Services Inc - TradingKey
West Pharmaceutical Services Inc (WST) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
West Pharmaceutical Services Inc (WST) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
West Pharmaceutical stock slips to weekly low amid conflicting momentum signals - Traders Union
Why West Pharmaceutical’s NovaPure plungers quietly matter for injectable drugs - AD HOC NEWS
West Pharmaceutical Services Inc (WST) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
West Pharmaceutical Services Inc (WST) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
West Pharmaceutical Services Inc (WST) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
West Pharmaceutical Services Inc (WST) Institutional Confidence - TradingKey
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
West Pharmaceutical Services Strengthens Support for China’s Biologics Ecosystem with Integrated Prefillable Syringe System Launch at CPHI China 2026 - 巴士的報
Aluminum Crimp Vial Seals Market Forecast to 2035: Growth Accelerates on Biologic Drug Surge and RTU Adoption - IndexBox
Reasons to Retain Baxter International Stock in Your Portfolio for Now - TradingView
West pharmaceutical services strengthens support for china’s biologics ecosystem with integrated prefillable syringe system launch at CPHI China 2026 - The Sun Malaysia
West Pharmaceutical Services Strengthens Support for China’s Biologics Ecosystem with Integrated Prefillable Syringe System Launch at CPHI China 2026 #WestPharmaceuticalServices - Media OutReach Newswire
New release highlights: Westar Select Ready Pack vials target small-batch biologics - AD HOC NEWS
New price band, same precision: West’s Stelmi Ready Pack seeks broader biologics use - AD HOC NEWS
How Investors May Respond To West Pharmaceutical Services (WST) Upgraded 2026 Outlook And Biologics Momentum - Yahoo Finance
Is West Pharmaceutical Stock Outperforming the S&P 500? - Barchart.com
West Pharmaceutical Stock (US9523901012): Quiet trading day keeps valuation in focus - AD HOC NEWS
West Pharmaceutical Services (WST) Stock Valuation Check After Recent Momentum And Premium P/E Ratio - Sahm
West Pharmaceutical Services (WST) Is an Injectable-Drug Infrastructure Story, Not Just a Packaging Supplier - AlphaStreet
Is Wall Street bullish or bearish on West Pharmaceutical Services stock? - MSN
West Pharmaceutical Stock (US9553061055): Valuation Metrics Under the Microscope on a Quiet Friday - AD HOC NEWS
West Pharmaceutical Stock (US9523901012): Valuation Metrics Under the Microscope - AD HOC NEWS
West Pharma’s GLP-1 Tailwinds Come With A Cybersecurity Footnote - Finimize
West NovaGuard® SA Pro Safety System Recognized for Excellence in Design and User Experience at the India Packaging Awards - Devdiscourse
Reasons to Add Veeva Systems Stock to Your Portfolio for Now - TradingView
West Pharmaceutical Names Thermo Fisher Executive as CEO - MyChesCo
AMN Expands Language Services Portfolio With Jaide Health Deal - TradingView
Motley Fool Wealth Management LLC Reduces Holdings in West Pharmaceutical Services, Inc. $WST - MarketBeat
Here's what to expect from West Pharmaceutical's next earnings report - MSN
West Pharma raised to overweight at Barclays on fundamentals - MSN
2.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):